Cargando…

Identification of genes contributing to cisplatin resistance in osteosarcoma cells

Osteosarcomas are prevalent in children and young adults and have a high recurrence rate. Cisplatin, doxorubicin, and methotrexate are common adjuvant chemotherapy drugs for treatment of osteosarcoma, but multidrug resistance is a growing problem. Therefore, understanding the molecular mechanisms of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Mingzhong, Dai, Haoping, Gu, Qingwen, Xiao, Changming, Wang, Haozhong, Lei, Yang, Wu, Chunxiao, Li, Xuening, Lin, Birong, Li, Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808595/ https://www.ncbi.nlm.nih.gov/pubmed/36408691 http://dx.doi.org/10.1002/2211-5463.13524

Ejemplares similares

ITGB3 promotes cisplatin resistance in osteosarcoma tumors
por: Li, Qian, et al.
Publicado: (2023)

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor
por: Peng, Daohu, et al.
Publicado: (2021)

GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
por: Xie, Chaofan, et al.
Publicado: (2021)

Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma
por: Liu, Yufeng, et al.
Publicado: (2020)

Circular RNA expression pattern in cisplatin-resistant osteosarcoma cells
por: Han, Jianhua, et al.
Publicado: (2020)

The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
por: Xu, Liang, et al.
Publicado: (2020)

Hedgehog/GLI1 signaling pathway regulates the resistance to cisplatin in human osteosarcoma
por: Chen, Daosen, et al.
Publicado: (2021)

Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
por: Wu, Zhihong, et al.
Publicado: (2011)

MicroRNA-22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
por: Meng, Chen-Yang, et al.
Publicado: (2020)

Association between sleep duration and sarcopenia among community-dwelling older adults: A cross-sectional study
por: Hu, Xiaoyi, et al.
Publicado: (2017)

Malnutrition-sarcopenia syndrome predicts mortality in hospitalized older patients
por: Hu, Xiaoyi, et al.
Publicado: (2017)

Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study
por: Yang, Ming, et al.
Publicado: (2016)

Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
por: Sun, Xilong, et al.
Publicado: (2017)

Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1
por: Kun-Peng, Zhu, et al.
Publicado: (2018)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma
por: Tsai, Hsiao-Chi, et al.
Publicado: (2014)

Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer
por: Gao, Yanan, et al.
Publicado: (2021)

MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma
por: Song, L., et al.
Publicado: (2017)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

Predicting long-term mortality in hospitalized elderly patients using the new ESPEN definition
por: Jiang, Jiaojiao, et al.
Publicado: (2017)

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
por: Zhou, Yong, et al.
Publicado: (2014)

The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma
por: Niu, Jianfang, et al.
Publicado: (2022)

Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
por: Cui, Yong, et al.
Publicado: (2018)

Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells
por: Giacomini, Isabella, et al.
Publicado: (2023)

Circular RNA circVRK1 suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating zinc finger protein ZNF652 expression via microRNA miR-337-3p
por: Cheng, Cheng, et al.
Publicado: (2021)

The Synergistic Reducing Drug Resistance Effect of Cisplatin and Ursolic Acid on Osteosarcoma through a Multistep Mechanism Involving Ferritinophagy
por: Tang, Zhen, et al.
Publicado: (2021)

Sestrin2-Mediated Autophagy Contributes to Drug Resistance via Endoplasmic Reticulum Stress in Human Osteosarcoma
por: Tang, Zhen, et al.
Publicado: (2021)

Exosomal CTCF Confers Cisplatin Resistance in Osteosarcoma by Promoting Autophagy via the IGF2-AS/miR-579-3p/MSH6 Axis
por: Zhan, Haibo, et al.
Publicado: (2022)

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin
por: Liu, Qing, et al.
Publicado: (2020)

Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
por: Zhang, Guoyou, et al.
Publicado: (2011)

Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells
por: Zhen, Yun-fang, et al.
Publicado: (2016)

SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381
por: Mi, Hailong, et al.
Publicado: (2020)

Cisplatin-resistant osteosarcoma cells possess cancer stem cell properties in a mouse model
por: Yang, Jian, et al.
Publicado: (2016)

Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines
por: Yang, Xiao-rong, et al.
Publicado: (2015)

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

Corrigendum: Sestrin2-mediated autophagy contributes to drug resistance via endoplasmic reticulum stress in human osteosarcoma
por: Tang, Zhen, et al.
Publicado: (2022)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022)

Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma
por: Ren, Xiaojun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1vldd4hqo9ovsgg6ndgrvhilt9